VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NHPAPNational Healthcare Properties, Inc.
$23.12$655M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. NHPAP
  4. Financial Ratios

National Healthcare Properties, Inc. (NHPAP) Financial Ratios

Latest Ratios: P/E Ratio -9.2x · EV/EBITDA 20.2x · ROE -8.9%. (2014–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

NHPAP Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$655M$543M$418M$461M$593M$717M$655M$696M———
Enterprise Value$1.7B$1.6B$1.5B$1.6B$1.7B$1.8B$1.8B$1.7B———
P/E Ratio →-9.21——————————
P/S Ratio1.911.591.181.331.772.181.721.86———
P/B Ratio1.080.900.610.510.590.690.680.63———
P/FCF————1964.2236.2132.8922.68———
P/OCF94.1878.06—21.3320.9618.4515.6714.68———

P/E links to full P/E history page with 30-year chart

NHPAP EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—4.594.374.604.935.324.744.65———
EV / EBITDA20.1818.84—20.3932.7941.4329.6135.40———
EV / EBIT510.4075.12—————————
EV / FCF————5485.5188.4590.8456.80———

NHPAP Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin36.0%36.0%37.5%37.0%36.4%37.5%36.2%37.5%39.0%8.0%3.6%
Operating Margin1.0%1.0%-34.9%-1.4%-9.4%-11.4%-5.2%-8.5%-0.9%2.0%-1.4%
Net Profit Margin-16.8%-16.8%-53.6%-20.9%-23.7%-25.9%-19.9%-23.4%-14.6%-13.7%-6.9%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE-8.9%-8.9%-23.9%-7.6%-7.8%-8.5%-7.3%-7.5%-4.1%-3.0%-1.3%
ROA-3.2%-3.2%-9.3%-3.3%-3.6%-3.8%-3.3%-3.7%-2.2%-1.9%-0.9%
ROIC0.1%0.1%-4.8%-0.2%-1.1%-1.3%-0.7%-1.1%-0.1%0.2%-0.1%
ROCE0.2%0.2%-7.7%-0.3%-1.9%-2.3%-1.2%-1.9%-0.1%0.3%-0.2%

NHPAP Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity1.801.801.671.311.121.051.281.030.870.710.43
Debt / EBITDA13.0313.03—15.0822.1125.8820.0723.2113.5311.466.81
Net Debt / Equity—1.701.631.261.060.991.200.950.800.630.41
Net Debt / EBITDA12.3412.34—14.4821.0524.4618.8921.2612.3810.246.46
Debt / FCF————3521.2952.2457.9534.1224.0315.408.58
Interest Coverage0.290.29-1.53-0.09-0.53-0.78-0.39-0.57-0.07——

NHPAP Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio0.410.410.210.280.170.200.160.31———
Quick Ratio0.410.410.210.280.170.200.160.31———
Cash Ratio0.170.170.050.110.090.110.100.14———
Asset Turnover—0.200.180.160.150.150.170.160.150.130.14
Inventory Turnover———————————
Days Sales Outstanding———————————

NHPAP Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield2.1%2.5%3.3%3.0%2.3%0.7%4.8%7.4%———
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield———————————
FCF Yield————0.1%2.8%3.0%4.4%———
Buyback Yield0.8%1.0%0.0%0.0%0.0%0.0%1.6%3.0%———
Total Shareholder Yield2.9%3.5%3.3%3.0%2.3%0.7%6.4%10.4%———
Shares Outstanding—$28M$28M$28M$28M$28M$28M$28M$27M$27M$26M

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Operational margin volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

NOI Margins Under Structural Pressure

As reported in quarterly financial filings, NHPAP's NOI margin has fluctuated between 33.4% and 38.7%, indicating that the firm's property-level profitability remains highly sensitive to inflationary labor costs and operational inefficiencies within the senior housing operating segment, which currently lacks the scale to achieve consistent margin expansion.

The inability to maintain a stable NOI margin suggests that the company's operational model is struggling to absorb rising costs, particularly within the SHOP segment. Investors should monitor whether management can transition toward more stable triple-net lease structures, as the current reliance on variable-cost operations appears to be a primary driver of the firm's inconsistent profitability.

Dividend Sustainability Remains Highly Uncertain

Based on the provided quarterly data, the FFO payout ratio has exhibited extreme volatility, reaching as high as 93.4% in 2024Q4, which suggests that dividend distributions are frequently unsupported by recurring operational cash flow and may be reliant on non-recurring capital sources or cash reserves.

The erratic nature of the FFO payout ratio indicates that the dividend is not currently backed by a reliable margin of safety. Given the persistent negative net income and the volatility in AFFO, the current payout policy warrants significant skepticism regarding its long-term viability without a fundamental improvement in property-level performance.

Leverage Profile Reflects Structural Fragility

According to the company's balance sheet data, the debt-to-equity ratio has climbed from 1.31 in 2023Q4 to 1.76 in 2026Q1, signaling that the firm's leverage profile is deteriorating as equity value is eroded by consistent net losses and potential asset impairments across the portfolio.

The rising debt-to-equity ratio, coupled with weak interest coverage ratios that have frequently dipped below 1.0x, suggests that the company's ability to service its debt obligations is increasingly constrained. This trend indicates a vulnerable balance sheet that may struggle to navigate a higher-interest-rate environment without further capital erosion.

Misapplication of Standard P/E Multiples

As noted in financial analysis, the market's reliance on standard P/E ratios for NHPAP is fundamentally flawed because it fails to account for the massive non-cash depreciation charges inherent in real estate, which consistently mask the underlying operational cash burn occurring within the senior housing segment.

Investors should prioritize FFO and AFFO over P/E, as the latter obscures the true economic reality of the company's profitability by treating depreciation as a standard expense rather than a non-cash accounting adjustment. Relying on P/E in this context leads to a distorted valuation that ignores the firm's inability to generate positive net income.

Download Financial Ratios Data

Includes 30+ ratios · 12 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

NHPAP — Frequently Asked Questions

Quick answers to the most common questions about buying NHPAP stock.

What is National Healthcare Properties, Inc.'s P/E ratio?

National Healthcare Properties, Inc.'s current P/E ratio is -9.2x. This places it at the 50th percentile of its historical range.

What is National Healthcare Properties, Inc.'s EV/EBITDA?

National Healthcare Properties, Inc.'s current EV/EBITDA is 20.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 29.7x.

What is National Healthcare Properties, Inc.'s ROE?

National Healthcare Properties, Inc.'s return on equity (ROE) is -8.9%. The historical average is -7.0%.

Is NHPAP stock overvalued?

Based on historical data, National Healthcare Properties, Inc. is trading at a P/E of -9.2x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is National Healthcare Properties, Inc.'s dividend yield?

National Healthcare Properties, Inc.'s current dividend yield is 2.05%.

What are National Healthcare Properties, Inc.'s profit margins?

National Healthcare Properties, Inc. has 36.0% gross margin and 1.0% operating margin.

How much debt does National Healthcare Properties, Inc. have?

National Healthcare Properties, Inc.'s Debt/EBITDA ratio is 13.0x, indicating high leverage. A ratio above 4x may signal elevated financial risk.